MOROSINI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 961
EU - Europa 740
AS - Asia 399
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 1
Totale 2.106
Nazione #
US - Stati Uniti d'America 956
CN - Cina 395
IE - Irlanda 272
FI - Finlandia 111
UA - Ucraina 108
DE - Germania 80
IT - Italia 78
SE - Svezia 39
GB - Regno Unito 33
FR - Francia 10
BE - Belgio 5
CA - Canada 5
EU - Europa 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IR - Iran 2
RU - Federazione Russa 2
IN - India 1
MU - Mauritius 1
NL - Olanda 1
PL - Polonia 1
TH - Thailandia 1
Totale 2.106
Città #
Dublin 272
Chandler 251
Jacksonville 133
Ashburn 97
Nanjing 91
Beijing 81
Helsinki 59
Princeton 41
Lawrence 38
Nanchang 37
New York 36
Pavia 33
Shenyang 33
Wilmington 31
Hebei 30
Medford 29
Changsha 26
Jiaxing 23
Shanghai 23
Boardman 18
Ann Arbor 16
Hangzhou 16
Tianjin 16
Los Angeles 14
Washington 13
Seattle 11
Milan 10
Verona 10
Woodbridge 10
Fairfield 7
Brussels 5
Auburn Hills 4
Ningbo 4
Norwalk 4
Taizhou 4
Toronto 4
Berlin 3
Falkenstein 3
Houston 3
Jinan 3
Trieste 3
Bari 2
Brescia 2
Gallarate 2
Ostuni 2
Romainville 2
Settimo Torinese 2
Amsterdam 1
Aosta 1
Bangkok 1
Busto Arsizio 1
Des Moines 1
Esslingen am Neckar 1
Fuzhou 1
Gropello Cairoli 1
Gunzenhausen 1
Kemerovo 1
Kunming 1
Leawood 1
Markham 1
Pune 1
Redwood City 1
Rockville 1
Tappahannock 1
Tehran 1
Wenzhou 1
Zhengzhou 1
Totale 1.577
Nome #
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 88
A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports 82
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 74
Ex vivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis 71
Specific Anti-CMV Reactivity in BAL: A Useful Tool 71
Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection 70
Systemic inflammatory response and downmodulation of peripheral CD25(+)Foxp3(+) T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer 69
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 69
Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations 68
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors 65
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 64
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes 63
Effects of continuous or pulsed exposure to rifabutin and sparfloxacin on the intracellular growth of Staphylococcus aureus and Mycobacterium tuberculosis 62
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 60
Experience with Cylex Immune Cell Function Assay in Clinical Immune Monitoring of Lung Transplant Recipients 58
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis 56
Possible Disease Markers in BAL Fluid of BOS Patients 56
A survey of antimicrobial drug resistance in respiratory tract pathogens, isolated in a northern Italian teaching hospital between 1990 and 1999 55
Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors 55
Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection 54
Regulatory T cells in kidney transplant recipients. 53
Mesenchymal cells isolated from the airways of BOS patients as targets of innovative drug-loaded nanoparticles 53
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. 53
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients 52
Virulence of Mycobacterium tuberculosis affects inteleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes 51
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 51
Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome 48
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients 46
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 46
Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study 45
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 45
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 43
Long-term off-line extracorporeal photochemotherapy in patients with chronic lung allograft rejection not responsive to conventional treatment: A 10-year single-centre analysis 42
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: An in vitro study 39
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 38
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 35
Peripheral CD19+CD24highCD38high B-regulatory cells in lung transplant recipients 35
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome 28
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 27
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 10
Totale 2.150
Categoria #
all - tutte 7.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 2 0 6
2019/2020440 117 147 6 18 0 19 10 22 0 64 37 0
2020/2021219 26 17 6 21 2 31 3 47 7 30 24 5
2021/2022155 8 0 4 3 0 3 2 6 11 6 25 87
2022/2023731 72 67 2 58 61 74 0 38 326 6 18 9
2023/2024346 60 64 18 17 24 99 10 33 1 20 0 0
Totale 2.150